I would wait for Warsh’s Jackson Hole tone before rotating aggressively back into tech.
The Treasury intervention is meaningful, but I would not interpret it as a durable reversal in long-term yields. The 30-year yield had reached about 5.34%, its highest since 2007, before Treasury announced it would at least double long-duration buybacks to $4bn per operation.
The bigger issue is the Fed. July's minutes were more hawkish than the headline "hold" suggests: three officials wanted a 25bp hike, several saw inflation as broad-based, and there was no meaningful discussion supporting a cut. Markets are even assigning better-than-even odds to a hike by October or December.
So my positioning would be:
Tech: cautiously add, not chase. Lower yields provide exactly the relief that high-duration AI/semiconductor valuations need, but if Warsh signals that inflation remains unacceptable, the 30-year can retest 5.3% despite Treasury intervention.
Healthcare: keep holding. It has relative-strength characteristics if rates remain elevated and tech continues consolidating.
Cash: retain some. Jackson Hole could create a sharp repricing either way.
My preferred setup is healthcare + selective tech, rather than a wholesale rotation. If Warsh sounds dovish while long yields stay below ~5.2%, I would become substantially more bullish on Nvidia, semiconductors and other long-duration growth names. If he sounds hawkish, I would rather own healthcare and wait.
**The Treasury just showed there is a pain threshold for yields. Warsh will tell us whether the Fed is willing to defend it.**
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
- fluffik·08-20 17:03I’m staying overweight healthcare here. Q2 showed better pricing power and steadier cash flow than tech, which matters way more if yields keep whipping aroundLikeReport
- Jim1995·08-20 17:03RSI bounce matters, but 30Y back above 5.3% probably kills any clean Nvidia breakout. Jackson Hole is the real test for higher-for-longer pricingLikeReport